These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 38511140)

  • 1. Ferroptosis in hepatocellular carcinoma, from mechanism to effect.
    Jiang S; Zhang G; Ma Y; Wu D; Xie D; Zhou S; Jiang X
    Front Oncol; 2024; 14():1350011. PubMed ID: 38511140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma.
    Huang Z; Xia H; Cui Y; Yam JWP; Xu Y
    J Clin Transl Hepatol; 2023 Feb; 11(1):207-218. PubMed ID: 36406319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis: a new promising target for hepatocellular carcinoma therapy.
    Xu Q; Ren L; Ren N; Yang Y; Pan J; Zheng Y; Wang G
    Mol Cell Biochem; 2023 Dec; ():. PubMed ID: 38051404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breaking the Barriers of Therapy Resistance: Harnessing Ferroptosis for Effective Hepatocellular Carcinoma Therapy.
    Lv X; Lan G; Zhu L; Guo Q
    J Hepatocell Carcinoma; 2024; 11():1265-1278. PubMed ID: 38974015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer.
    Cheu JW; Lee D; Li Q; Goh CC; Bao MH; Yuen VW; Zhang MS; Yang C; Chan CY; Tse AP; Sit GF; Liu CX; Ng IO; Wong CM; Wong CC
    Cell Mol Gastroenterol Hepatol; 2023; 16(1):133-159. PubMed ID: 36893885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parthenolide induces rapid thiol oxidation that leads to ferroptosis in hepatocellular carcinoma cells.
    LoBianco FV; Krager KJ; Johnson E; Godwin CO; Allen AR; Crooks PA; Compadre CM; Borrelli MJ; Aykin-Burns N
    Front Toxicol; 2022; 4():936149. PubMed ID: 36591540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From synergy to resistance: Navigating the complex relationship between sorafenib and ferroptosis in hepatocellular carcinoma.
    Wang Z; Zhou C; Zhang Y; Tian X; Wang H; Wu J; Jiang S
    Biomed Pharmacother; 2024 Jan; 170():116074. PubMed ID: 38147732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Ferroptosis-Related Signature for Prediction of Prognosis, Immune Profiles and Drug Sensitivity in Hepatocellular Carcinoma Patients.
    Zhao C; Zhang Z; Tao J
    Curr Oncol; 2022 Sep; 29(10):6992-7011. PubMed ID: 36290827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation.
    Bekric D; Ocker M; Mayr C; Stintzing S; Ritter M; Kiesslich T; Neureiter D
    Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive characterization of ferroptosis in hepatocellular carcinoma revealing the association with prognosis and tumor immune microenvironment.
    Zhu J; Xu X; Jiang M; Yang F; Mei Y; Zhang X
    Front Oncol; 2023; 13():1145380. PubMed ID: 37051544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma.
    Zhang Z; Zhang W; Wang Y; Wan T; Hu B; Li C; Ge X; Lu S
    Front Cell Dev Biol; 2022; 10():792676. PubMed ID: 35295858
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Li Y; Zhang J; Zhang K; Chen Y; Wang W; Chen H; Zou Z; Li Y; Dai M
    Front Oncol; 2022; 12():693395. PubMed ID: 35321425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of ferroptosis in hepatocellular carcinoma.
    Nie J; Lin B; Zhou M; Wu L; Zheng T
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2329-2337. PubMed ID: 30167889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of ferroptosis-related genes for overall survival prediction in hepatocellular carcinoma.
    Luo L; Yao X; Xiang J; Huang F; Luo H
    Sci Rep; 2022 Jun; 12(1):10007. PubMed ID: 35705729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Analysis Reveals Critical Ferroptosis Regulators and FTL Contribute to Cancer Progression in Hepatocellular Carcinoma.
    Ke S; Wang C; Su Z; Lin S; Wu G
    Front Genet; 2022; 13():897683. PubMed ID: 35651950
    [No Abstract]   [Full Text] [Related]  

  • 16. Iron accumulation and lipid peroxidation: implication of ferroptosis in hepatocellular carcinoma.
    Li X; Meng F; Wang H; Sun L; Chang S; Li G; Chen F
    Front Endocrinol (Lausanne); 2023; 14():1319969. PubMed ID: 38274225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of genomic selection and experimental techniques to predict cell death and immunotherapeutic efficacy of ferroptosis-related CXCL2 in hepatocellular carcinoma.
    Yi Q; Liang Q; Liu Y; Gong Z; Yan Y
    Front Oncol; 2022; 12():998736. PubMed ID: 36276119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An inflammation-associated ferroptosis signature optimizes the diagnosis, prognosis evaluation and immunotherapy options in hepatocellular carcinoma.
    Ruan WY; Zhang L; Lei S; Zeng ZR; Yang YS; Cao WP; Hao QY; Lu M; Tian XB; Peng PL
    J Cell Mol Med; 2023 Jul; 27(13):1820-1835. PubMed ID: 37248957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma.
    Li L; Wang X; Xu H; Liu X; Xu K
    Front Mol Biosci; 2022; 9():947208. PubMed ID: 36052168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma.
    Li G; Liu Y; Zhang Y; Xu Y; Zhang J; Wei X; Zhang Z; Zhang C; Feng J; Li Q; Wang G
    Front Immunol; 2022; 13():929089. PubMed ID: 35874689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.